The changes in the blood toxicity of some antitumoral chemotherapeutic agents in the presence of erythropoiesis activation by bleeding are evaluated. The general toxicity seems to be unaffected but the damage to erythropoiesis proved, in absolute terms, to be more severe in the bled animals. The recovery of hematopoiesis was slower after some drugs than others. These results are discussed in the light of present knowledge of hematopoietic kinetics and of the relationships between antiblastic drugs and stamina] hematopoietic compartments.
Get full access to this article
View all access options for this article.
References
1.
AlgenstaedtD.: Quantitative Veranderungen des Zellgehaltes von Blut und Knochenmark unter der Chemotherapie menschlicher Leukaemien.Arztl. Wschr.,14: 461, 1959.
2.
BasergaA., MarinoneG., CastellottiP.E.: Sulle modificazioni delle cellule midollari da azoiprite.Haematologica, 23: 229–233, 1949.
3.
BelcherE. H., Harris EileenB.: Studies of plasma volume, red cell volume and total blood volume in young growing rats.J. Physiol., 139: 64–78, 1957.
4.
BlackettN. M.: Investigation of bone-marrow stem cell proliferation in normal, anemic, and irradiated rats, using methotrexate and tritiated thymidine.J. Nat. Cancer Inst.,41, 909–918, 1968.
5.
BlackettN. M., AdamsK.: Cell proliferation and the action of cytotoxic agents on haemopoietic tissue.Brit. J. Haemat., 23: 751–758, 1972.
6.
BoggsD. R., MarshJ. C., ChervenickP. A., CartwrightG. E., WintrobeM. M.: Factors influencing hematopoietic spleen colony formation in irradiated mice.The different effects of foreign plasma, endotoxin, and bleeding on colony-forming cell kinetics. Radiat. Research,35: 68, 1968.
7.
BoggsS. S., ChervenickP. A., BoggsD. R.: The effect of postirradiation bleeding or endotoxin on proliferation and differentiation of hematopoietic stem cell.Blood, 40: 375–389, 1972.
8.
BruceW. R., MeekerB. E., ValerioteF. A.: Comparison of the sensitivity of normal haematopoietic and transplanted lymphoma colony-forming cell to chemoterapeutic agents administered in vivo.J. Nat. Cancer Inst., 37: 233–245, 1966.
9.
BruceW. R., MeekerB. E.: Comparison of the sensitivity of haematopoietic colony-forming cells in different proliferative states to 5-Fluoro-Uracil.J. Nat. Cancer Inst., 38: 401–405, 1967.
10.
CardinaliG., CardinaliG., Aboul-EneinM.: Studies on the antimitotic activity of leurocristine (vincristine).Blood, 21: 102–110, 1963.
11.
CardinaliG., CardinaliG.: Studies on the hematological effects of vinblastine (VLB) and vincristine (VCR).Proc. 10th Congr. Europ. Soc. Haemat., part 11, pp. 831–839, Strasbourg, 1965.
12.
ChevernickP. A., BoggsD. R.: Patterns of proliferation and differentiation of hemopoietic stem cells after compartement depletion.Blood, 37: 568–580, 1971.
13.
ConstableT. B., BlackettN. M.: Comparison of effect of four cytotoxic agents on granulocytic and erythroid repopulating ablity of rat bone marrow.J. Nat. Cancer Inst., 48: 941–948, 1972.
14.
ConstableT. B., BlackettN. M.: Effect of cytotoxic agents on the maturing granulocytic and erythroid cells of rats.J. Nat. Cancer Inst., 50: 512–521, 1973.
15.
CsanyE.:, ElsonL. A.: Action of « Mustard » and « Myleran » type alkylating agents on the cellular proliferation and DNA metabolism of the hemopoietic organs of the rat.Ann. Rep. Brit. Emp. Cancer Campaign,11: 32, 1967.
16.
Dacie e Lewis: Manuale di tecnica ematologica italiana, Piccin, Padova, 1972.
17.
DewysW. D., GoldinA., MantelM.: Hematopoietic recovery after large doses of cyclophosphamide: correlation of proliferative state with sensitivity.Cancer Res., 30: 1692–1697, 1970.
18.
DouglasI. D. C., PriceL. A.: Bone-marrow toxicity of metotrexate: a reassessment Brit.J. Haemat., 24: 625–631, 1973.
19.
DunnC. D. R.: Cell proliferation and drug resistance in the response of colony-forming units of rat bone marrow to repeated doses of cytotoxic agents.J. Nat. Cancer Inst., 48: 639–649, 1972.
20.
DunnC. D. R.: The effect of certain nitrogen mustard derivatives on bone marrow colony-forming units and erithroid repopulating ability.I. Rats. Europ. J. Cancer, 8: 509–516, 1972.
21.
DunnC. D. R., The proliferative capacity of haemopoietic colony-forming units in the rat.Cell. Tissue Kinet., 6: 55–67, 1973.
22.
DunnC. D. R., ElsonL. A.: Haematopoietic spleen colonies in rats treated with cytotoxic drugs.Rev. Franç. étud. Clin. Biol., 14: 57–59, 1969.
23.
DunnC. D. R., ElsonL. A.: Au apparent discrepancy between the number of colony-forming units transplanted and survival of Busulphan lethally treated rats.J. Cell. Physiol., 76: 215–224, 1970.
24.
DunnC. D. R., ElsonL. A.: Quantitative studies of haemopoietic spleen colonies in rats trated with cytotoxic chemicals.Brit. J. Haemat., 19: 755–764, 1970.
25.
ElsonL. A.: A comparison of radiation and radiomimetic chemicals on the bood.Brit. J. Haemat., 1: 104–116, 1955.
26.
ElsonL. A., DunnC. D. R.: The relationship between blood response pattern to cytotoxic alkylating agents and depression of haemopoietic colony-forming units. pp. 200. In: Proc. 13th Int. Congr. Haemat.LehmannsJ. F. (ed.), Springer-Verlag, Munchen-New York, 1970.
27.
ElsonL. A., GaltonD. A. G., TillM.: The action of chlorambucil (CB 1348) and busulphan (Myleran) on the haemopoietic organs of the rat.Brit. J. Haemat., 4: 355–371, 1958.
28.
EskucheI., HodgsonG. S.: Radiosensitivity of erythropoiesis as a function of its activity. pp. 163–171. In: Proc. 5th Interamerican Symp. on Peaceful Application of Nuclear Energy, Washington, Pan. Am. Union, 1965.
29.
FieschiA., SacchettiC., SalvidioE., TizianelloA.: Alcuni aspetti della bioregolazione delle cellule emopoietiche in cavie trattate con antimetaboliti.Boll. Soc. Ital. Emat.,6: 1958.
30.
FisherJ. W., RohB. L.: Influence of alkylating agents on kidney erytropoietin production.Cancer Res., 24: 983–988, 1964.
31.
FriedW., JohnsonC.: The effect of cyclophosphamide on hematopoietic stem cells.Radiat. Res., 36: 521–527, 1968.
32.
HambschK., OttoW.: Die beeinflussung des hamopoetischen System der Weissen ratte durch einen n-lost-cyclophosphamidester (Endoxan-Asta).Folia Haemat., 86: 174–189, 1967.
33.
HarrisE. B., AponteL.: The effect of nitrogen mustard on the haemopoietic stem cells of the bone marrow in the rat.Cell. Tissue Kinet., 1: 289–298, 1968.
HodgsonG., EskucheI.: Study of the effect of chemotherapeutic agents on the « early » and « late » responses to erythropoietin.Proc. Soc. Exp. Biol. Med., 127: 328–331, 1968.
36.
HostH.: Effect of intermittent hypoxia on regeneration of haemopoiesis in rats treated with cyclophosphamide or total body irradiation.Scand. J. Haemat., 3: 193–204, 1966.
37.
HostH., SkjaelaaenP.: Comparative effects of cyclophosphamide and total body irradiation on erythropoietin production in rats.Scand. J. Haemat., 3: 154–157, 1966.
38.
HryniukW. M., BertinoJ. R.: Rationale for the selection of chemiotherapeutic agents.Advances Intern. Med., 15: 267–297, 1969.
39.
JacobsonL. O., MarksE. K., GastonE., BlockM. H.: The effect of nitrogen mustard on induced erythroblastic hyperplasia in rabbits.J. Lab. Clin. Med., 34: 902–924, 1949.
40.
JosvasenN., BoyumA.: Haematopoiesis in busulphan-treated mice.A comparison between two different stem cell assays. Scand. J. Haemat., 11: 78–86, 1973.
41.
KaulM., HudsonG.: Cell-degeneration pattern in bone marrow and blood of guinea pigs following administration of cyclophosphamide.Acta Haemat., 42: 42–49, 1969.
42.
KaulM., HudsonG.: Recovery of haemopoiesis after cyclophosphamide.Acta Haemat., 42: 170–179, 1969.
43.
KielarR. A., MeinekeH. A.: Survival of lethally X-irradiated rats receiving marrow from normal or Chlorambucil-treated donor rats.Radiat. Res., 20: 1–7, 1963.
44.
KubanekB., FerrariL., TylerW. S., HowardD., JayS., StohlmanF.Jr.: Regulation of erythropoiesis.XXIII. Dissociation between stem cell and erythroid response to hypoxia. Blood, 32: 586–596, 1968.
LawrenceJ. S., CraddockC. G.Jr.: Stem cell competition: the response to antineutrophilic serum as affected by hemorrhage.J. Lab. Clin. Med., 72: 731–738, 1968.
47.
MarinoneG.: La syndrome d'arret mitotique.Le Sang, 27: 632–646, 1956.
48.
MarmontA. M., DamasioE. E.: The effects of two alkaloids derived from Vinca rosea on the malignant cells of Hodgkin's disease, lymphosarcoma and acute leukemia in vivo.Blood, 29: 1–21, 1967.
49.
MarshJ. C., BoggsD. R., ChervenickP. A., CartwrightG. E., WintrobeM. M.: Factors influencing hematopoietic spleen colony formation in irradiated mice.J. Cell. Physiol., 71: 65–76, 1968.
50.
MehrotraT. N., CardinaliG.: Effect of colchicine and Catharantus roseus (vinca rosea) alkaloids on mitosis of syrian hamster bone marrow cells.Ind. J. Pat. Bact.,8: 98, 1965.
51.
MetcalfD.: Cortisone action on serum colony stimulating factor and bone marrow in vitro colony-forming cells.Proc. Soc. Exp. Biol. Med., 132: 391–394, 1969.
52.
MetcalfD.: The effect of bleeding on the number of in vitro colony-forming cells in the bone marrow.Brit. J. Haemat., 16: 397–407, 1969.
53.
MillarJ. L., BlackettN. M.: The effect of various cytotoxic agents on the erythroid precursors in rat bone marrow.Brit. J. Haemat., 26: 535–541, 1974.
54.
MillarJ. L., ConstableT. B., BlackettN.M.: Delayed response to erythropoietin in polycythaemic animals treated with cytotoxic agents.Cell. Tissue Kinet., 7: 363–370, 1974.
55.
MorseB. S., RencriccaJ., StohlmanF.Jr.: Relationship of erythropoietin effectiveness to the generative cycle of erythroid precursor cell.Blood, 35: 761–774, 1970.
56.
MorseB. S., StohlmanF.Jr.: Regulation of erythropoiesis.XVIII. The effect of vincristine and erythropoietin on bone marrow. J. Clin. Invest., 45: 1341–1350, 1966.
57.
MurphyM. J.Jr., LordI. L.: Hematopoietic stem cell regulation.I. Acute effects of hypoxic-hypoxia on CFU kinetics, Blood, 42: 81–87, 1973.
58.
PannacciulliI.: Modificazioni del tasso e della maturazione reticolocitaria in animali trattati con antifolici ed antipurinici.Boll. Soc. Ital. Emat.,6: 1958.
59.
PannacciulliI.: Sensibilità delle cellule staminali agli antiblastici.Atti XXIV Congr. Naz. Soc. Ital. Ematol., Salice Terme, settembre, 1973.
60.
PorteousD. D., LajthaL. G.: On stem-cell recovery after irradiation.Brit. J. Haemat., 12: 177–188, 1966.
61.
PreislerH. D., HendersonE. S.: Effect of suppression of erythropoiesis on hematopoietic stem cells in the mouse.J. Cell. Physiol., 79: 103–110, 1971.
62.
RallD. P.: Selective aspects of chemotherapy in acute leukemia and Burkitt's tumor.Cancer, 21: 575–579, 1968.
63.
ReissmannK. R., SamorapoompichitS.: Effect of erythropoietin on early recovery of erythropoiesis in mice after sublethal dose of 5-fluorouracil.Proc. Soc. Exp. Biol. Med., 128: 898–901, 1968.
64.
ReissmannK. R., SamorapoompichitS.: Effect of erythropoietin on proliferation of erythroid stem cells in the absence of transplantable colony-forming units.Blood, 36: 287–296, 1970.
65.
ReissmannK. R., UdupaK. B.: Effect of erythropoietin on proliferation of erythropoietin-responsive cells.Cell Tissue Kinet., 5: 481–489, 1972.
66.
RencriccaN. J., RizzoliV., HowardD., DuffyP., StohlmannF.Jr.: Stem cell migration and proliferation during severe anemia.Blood, 36: 764–771, 1970.
67.
SkipperH. E.: Biochemical, biological, pharmacologic, toxicologic, kinetic and clinical (subhuman and human) relationships.Cancer, 21: 600–610, 1968.
68.
SmithL. H., WillardH. G.: Alteration of hemopoietic tissue as a factor influencing radiosensitivity of the mouse.Amer. J. Physiol., 216: 493–498, 1969.
69.
SmithW. W., WilsonS. M.: Effect of vinblastine and vincristine on survival and hemopoiesis in irradiated mice.J. Nat. Cancer Inst., 39: 1055–1066, 1967.
70.
SmithW. W., WilsonS. M., FredS. S.: Kinetics of stem cell depletion and proliferation: effects of vinblastine and vincristine in normal and irradiated mice.J. Nat. Cancer Inst.,40: 847, 1968.
71.
StohlmanF.Jr., CronkiteE. P., BrecherG.: Stimulation of erythropoiesis in irradiated dogs and rats.Proc. Soc. Exp. Biol. Med., 88: 402–406, 1955.
72.
StohlmanF.Jr., EbbeS., MorseB., HowardD., DonovanJ.: Regulation of erythropoiesis.XX. Kinetics of red cell production. Ann. N. Y. Acad. Sci., 149: 156–172, 1968.
SugaharaT., TanakaT.: Effect of bleeding after irradiation on survival of three strains of lethally-irradiated mice with different radiosensitivity.Int. J. Radiat. Biol., 18: 395–397, 1970.
75.
ThomasE. D., FliednerT. M., DorothyThomas, CronkiteE. P.: The problem of the stem cell: observations in dogs following nitrogen mustard.J. Lab. Clin. Med., 65: 794–803, 1965.
76.
TwentymanP. R., BlackettN. M.: Action of cytotoxic agents on the erythroid system of the mouse.J. Nat. Cancer Inst.,44: 117, 1970.
77.
UdupaK. B., OkamuraH., ReissmannK. R.: Granulopoiesis during myleran-induced suppression of transplantable hematopoietic stem cells.Blood, 39: 317–325, 1972.
78.
ValentineW. N., PearceM. L.: Studies on the radio-sensitivity of bone marrow.Blood, 7: 1–13, 1952.
79.
ValerioteF. A., BruceW. R., MeekerB. E.: Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells of mice to vinblastine administered in vivo.J. Nat. Cancer Inst., 36: 21–27, 1966.
80.
ValerioteF. A., CollinsD. C., BruceW. R.: Hematological recovery in the mouse following single doses of gamma radiation and cyclophosphamide.Radiat. Res., 33: 501–511, 1968.
81.
ValerioteF. A., TolenS.J.: Survival of hematopoietic and lymphoma colonyforming cells in vivo following the administration of a variety of alkylating agents.Cancer Res., 32: 470–476, 1972.
82.
Van PuttenL. M.: Are cell kinetic data relevant for the design of tumor chemotherapy schedules.Cell Tissue Kinet., 7: 493–503, 1974.
83.
Van PuttenL. M., LelieveldP.: Factors determining cell killing by chemotherapeutic agents in vivo.Europ. J. Cancer, 6: 313–321, 1970.
84.
Van PuttenL. M., LelieveldP.: Factor determining cell killing by chemotherapeutic agents in vivo.II. Melphalan, chlorambucil and nitrogen mustard. Europ. J. Cancer, 7: 11–16, 1971.
85.
VoglerW. R., MingioliE. S., GarwoodF. A.: The eflect of methotrexate on granulocytic stem cells and granulopoiesis.Cancer Res., 33: 1628–1633, 1973.
86.
WolfN. S., TrentinJ.: Differential proliferation of erythroid and granuloid spleen colonies following sublethal irradiation.J. Clin. Physiol., 75: 225–229, 1970.
